Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Recursion, a clinical stage TechBio company listed on Nasdaq, announced the Compensation Committee's approval of inducement restricted stock units (RSUs) totaling nearly 3 million shares granted to 33 new employees under its 2024 Inducement Equity Incentive Plan. The awards vest over a multi-year schedule and are intended to incentivize employee co…
Zevra Therapeutics, a commercial-stage biopharmaceutical company focused on rare diseases, announced the granting of stock options totaling 33,000 shares to four new employees as inducement awards under Nasdaq Rule 5635(c)(4). These options vest over four years and were approved by the company’s Compensation Committee to attract key talent.
U.S. equities finished higher after the close on Friday, with the Dow Jones Industrial Average rising 0.72% to a record close. The S&P 500 gained 0.22% and the NASDAQ Composite added 0.21%, with notable winners including IBM, Dell and NetApp, while several healthcare and retail names weighed on the session.
Sean Brynjelsen, President and Chief Executive Officer of Eton Pharmaceuticals, Inc., recently sold a substantial amount of the company's common stock. This transaction occurs against a backdrop of strong recent stock gains but also follows mixed first-quarter 2026 earnings reports and strategic developments regarding key drug commercialization rig…
Halliburton is under pressure from macro swings and geopolitical noise, but the underlying business is generating cash, beating Q1 estimates and trading well below recent highs. This trade idea lays out a concrete entry, stop and target for a long trade intended to capture a recovery as oilfield activity normalizes.
A director sale by Kyle, involving over $1 million in company stock, occurred as Timken Co. reported robust first-quarter 2026 earnings. Following these results, multiple major investment banks issued updated ratings and price targets for the stock, reflecting positive views on the company's growth strategy.
Gary Kent Wunderlich Jr., a director at Navitas Semiconductor Corp (NASDAQ:NVTS), executed sales totaling approximately $3.04 million worth of shares on May 28, 2026. This activity occurred as the company reported its Q1 2026 financial results and finalized a significant capital offering. The report details the breakdown of these transactions and p…
Armando Lins Netto, Group President of Brazil and U.S. Vehicle Payments at Corpay (CPAY), recently sold a significant amount of company stock across three transactions totaling approximately $6.12 million. This insider activity occurs as CPAY's shares trade near their 52-week high, following reports of strong first-quarter earnings for 2026 and key…
Navitas Semiconductor's CEO, Chris Allexandre, divested a portion of his holdings, selling shares worth $423,804. This transaction occurred against a backdrop of recent corporate activity, including the reporting of Q1 2026 financial results and the successful completion of an at-the-market stock offering.
S&P Global Ratings has affirmed South Africa’s sovereign ratings at BB (foreign currency) and BB+ (local currency) with a positive outlook, noting improved fiscal metrics including a third consecutive year of primary surpluses and higher-than-expected revenue in fiscal 2025. The agency lowered near-term growth expectations amid inflation and intere…
Recent filings indicate that Rachel Barthelemy Marcon, President of Doors at Owens Corning, sold shares of the company's common stock. This transaction occurred while Owens Corning simultaneously reported first-quarter financial results for 2026. The company announced an earnings per share (EPS) of $1.22, significantly surpassing analyst projection…
Senior Vice President and Chief Accounting Officer Robert L. Worshek recently sold $227,059 worth of Townsquare Media's Class A common stock. This sale occurred shortly after Mr. Worshek received significant grants of both stock awards and purchase options. The timing comes against a backdrop of TSQ shares increasing 46% over the past six months an…
S&P Global Ratings has affirmed Lithuania’s 'A/A-1' long- and short-term foreign and local currency sovereign credit ratings and maintained a stable outlook. The rating agency forecasts 3% GDP growth in 2026 supported by domestic demand, while higher defense outlays, rising net government debt and an expected current account deficit reflect fiscal …
Olaplex Holdings, Inc. disclosed a proposed settlement of pending shareholder derivative lawsuits filed in the U.S. District Court for the Central District of California. The settlement includes adoption of corporate governance reforms and payment of legal fees, subject to court approval. This settlement aims to avoid prolonged litigation and assoc…
Okeanis Eco Tankers Corp. held its 2026 Annual Meeting on May 29, where shareholders elected eight directors for the upcoming year and ratified Deloitte Certified Public Accountants S.A. as independent auditors for 2026. The company operates a modern fleet of scrubber-fitted tankers listed on both NYSE and Oslo Stock Exchange.
S&P Global Ratings affirmed Hungary's long- and short-term foreign and local currency sovereign ratings at 'BBB-/A-3' and maintained a negative outlook. The agency highlighted fiscal and economic vulnerabilities driven by large budget deficits, elevated debt and high interest costs, projecting a general government deficit of 6.75% of GDP in 2026 li…
Christopher Yea, Chief Development Officer at KalVista Pharmaceuticals, Inc., recently sold a significant block of common stock. This activity occurs alongside major corporate news regarding the pending acquisition of KalVista by Chiesi Group for $27.00 per share in cash, which has prompted adjustments from several analysts.
Director Paul Stuka increased his stake in InspireMD, Inc. (NSPR) through a recent SEC filing, acquiring 20,000 shares valued at $17,500. This purchase occurred as the stock trades near its five-two-week low. Separately, NSPR reported Q1 2026 earnings that beat analyst estimates, with revenue reaching $3.4 million and EPS of -$0.16, although manage…
The Chief Financial Officer and Interim President of electroCore, Inc. sold shares of the company's common stock on May 28, 2026. This transaction occurs as electrocore stock has experienced a substantial rally, trading near its 52-week high. Separately, recent corporate updates highlight robust first quarter revenue increases alongside an elevated…
Rocky Mountain Chocolate Factory, Inc. announced it will hold a conference call on June 2, 2026, to discuss its fiscal fourth quarter and full year 2026 financial results. The company is a leading franchisor of premium chocolate and confectionery stores with over 250 locations, primarily in the U.S.
Jade Biosciences announced a conference call to discuss interim Phase 1 healthy volunteer results for JADE101, their novel anti-APRIL monoclonal antibody targeting immunoglobulin A nephropathy (IgAN). The data is expected to inform dosing strategy and characterize the clinical profile of this potentially best-in-class therapy. JADE101 shows promisi…
The Chief Financial Officer of RADIANT LOGISTICS, INC (NASDAQ:RLGT), reported selling a significant amount of company common stock in late May. These insider sales occurred against a backdrop of the company's strong financial reporting for its fiscal third quarter of 2026. RLGT surpassed analyst expectations with an earnings per share (EPS) of $0.1…
Peoples Financial Corp announced a semi-annual cash dividend of $0.18 per common share, scheduled for June 11, 2026. This news coincided with the report that director George J. Sliman III purchased an additional 2,000 shares of company stock on May 29, 2026, increasing his direct holdings to 5,000 shares.
Arvinas, Inc., a clinical-stage biotech company specializing in targeted protein degradation therapies, announced its management will present at the Jefferies Global Healthcare Conference. The presentation will cover its PROTAC platform, FDA-approved drug VEPPANU™, and several investigational drugs targeting neurodegenerative diseases, cancers, and…
Kiniksa Pharmaceuticals International, plc announced management's participation in fireside chats at the Jefferies Global Healthcare Conference and Goldman Sachs Annual Global Healthcare Conference in June 2026. Presentations will be webcast live and available for replay on the company's website, highlighting the company's commitment to engaging wi…
